BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29425781)

  • 1. Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population.
    Vargas EJ; Pesta CM; Bali A; Ibegbu E; Bazerbachi F; Moore RL; Kumbhari V; Sharaiha RZ; Curry TW; DosSantos G; Schmitz R; Agnihotri A; Novikov AA; Pitt T; Dunlap MK; Herr A; Aronne L; Ledonne E; Kadouh HC; Cheskin LJ; Mundi MS; Acosta A; Gostout CJ; Abu Dayyeh BK
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1073-1080.e1. PubMed ID: 29425781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss.
    Agnihotri A; Xie A; Bartalos C; Kushnir V; Sullivan S; Islam S; Islam E; Lamet M; Lamet A; Farboudmanesch R; Overholt BF; Altawil J; Early DS; Bennett M; Lowe A; Mullady DK; Adeyeri CS; El Zein M; Mishra P; Fayad L; Dunlap M; Oberbach A; Cheskin LJ; Kalloo AN; Khashab MA; Kumbhari V
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1081-1088.e1. PubMed ID: 29481969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges.
    Marrero Torres RJ; Gregory F; Micames CG
    Surg Endosc; 2022 Jul; 36(7):5160-5166. PubMed ID: 34845556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy and Safety of the FDA-approved Intragastric Balloon Systems in a Clinical Setting.
    Swei E; Almuhaidb A; Sullivan S; Al-Shahrani A; D'Souza FR; Altayar O; Bell S; Maday R; Wagh MS; Mullady D; Bennett M; Early D; Kushnir V
    J Clin Gastroenterol; 2023 Jul; 57(6):578-585. PubMed ID: 35604348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective pilot study of the efficacy and safety of Elipse intragastric balloon: A single-center, single-surgeon experience.
    Al-Subaie S; Khalifa S; Buhaimed W; Al-Rashidi S
    Int J Surg; 2017 Dec; 48():16-22. PubMed ID: 28989057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filling the Void: A Review of Intragastric Balloons for Obesity.
    Laing P; Pham T; Taylor LJ; Fang J
    Dig Dis Sci; 2017 Jun; 62(6):1399-1408. PubMed ID: 28421456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intragastric balloon placements in a private practice setting.
    Mathus-Vliegen EM; Alders PR; Chuttani R; Scherpenisse J
    Endoscopy; 2015 Apr; 47(4):302-7. PubMed ID: 25479562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASSESSMENT OF WEIGHT LOSS AFTER NON-ADJUSTABLE AND ADJUSTABLE INTRAGASTRIC BALLOON USE.
    Schwaab ML; Usuy EN; Albuquerque MM; Moreira DM; Derossi VO; Usuy RT
    Arq Gastroenterol; 2020; 57(1):13-18. PubMed ID: 32294730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalization of Endoscopic Bariatric and Metabolic Therapies Based on Physiology: a Prospective Feasibility Study with a Single Fluid-Filled Intragastric Balloon.
    Lopez-Nava G; Jaruvongvanich V; Storm AC; Maselli DB; Bautista-Castaño I; Vargas EJ; Matar R; Acosta A; Abu Dayyeh BK
    Obes Surg; 2020 Sep; 30(9):3347-3353. PubMed ID: 32285333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
    Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
    Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis.
    Oster M; Hein N; Aksan A; Krammer H; Theodoridou S; Stein J
    Obes Facts; 2023; 16(1):89-98. PubMed ID: 36257288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.
    Diab AF; Abdurasul EM; Diab FH
    Obes Surg; 2019 Nov; 29(11):3542-3546. PubMed ID: 31267474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization.
    Moore RL; Seger MV; Garber SM; Smith AB; Nguyen RT; Shieh MK; Snow RG; Sullivan S
    Surg Obes Relat Dis; 2019 Mar; 15(3):417-423. PubMed ID: 30797717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric Balloon for Overweight Patients.
    Martins Fernandes FA; Carvalho GL; Lima DL; Rao P; Shadduck PP; Montandon ID; de Souza Barros J; Rodrigues IL
    JSLS; 2016; 20(1):. PubMed ID: 26955259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intragastric balloon on blood pressure reduction: A retrospective study in Eastern North Carolina.
    Samuel GO; Lambert K; Asagbra E; Harvin G; Ibegbu E
    World J Gastrointest Endosc; 2021 May; 13(5):115-124. PubMed ID: 34046149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of 12-Month Intra-gastric Balloon-Series of over 1100 Patients.
    Wiggins T; Sharma O; Sarfaraz Y; Fry H; Baker J; Singhal R
    Obes Surg; 2024 Jan; 34(1):176-182. PubMed ID: 38038905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy Comparison of Endoscopic Bariatric Therapies: 6-Month Versus 12-Month Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty.
    Kozłowska-Petriczko K; Pawlak KM; Wojciechowska K; Reiter A; Błaszczyk Ł; Szełemej J; Petriczko J; Wiechowska-Kozłowska A
    Obes Surg; 2023 Feb; 33(2):498-505. PubMed ID: 36525237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric balloon placement in the treatment of overweight and obesity: Experience at a Mexican referral center.
    Hernández-Lara AH; Almazán-Urbina FE; Santiago-Torres M; Rangel-Cruz E
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(4):410-415. PubMed ID: 32151349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial.
    Tønnesen CJ; Hjelmesæth J; Hofsø D; Tonstad S; Hertel JK; Heggen E; Johnson LK; Mathisen TE; Kalager M; Wieszczy P; Medhus AW; Løberg M; Aabakken L; Bretthauer M
    Scand J Gastroenterol; 2022 Feb; 57(2):232-238. PubMed ID: 34714203
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.